SK MS10

Drug Profile

SK MS10

Alternative Names: Cochinchina momordica seed extract; SK-MS10

Latest Information Update: 12 Jan 2016

Price : $50

At a glance

  • Originator SK Chemicals
  • Class Anti-inflammatories; Antiulcers; Herbal medicines
  • Mechanism of Action
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Discontinued Gastritis

Most Recent Events

  • 20 Jul 2015 No recent reports on development identified - Phase-II for Gastritis in South Korea (PO)
  • 31 Dec 2012 SK Chemicals completes a phase II trial in Gastritis in South Korea (NCT01578811)
  • 16 Apr 2012 Phase-II clinical trials in Gastritis in South Korea (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top